Inventor · disambiguated record
Min Yang
Also filed as: YANG MIN · YANG MIN AH
7 granted patents·12 pending applications·44 citations·filing 2011–2023
82Inventor score
Files withACETYLON PHARMACEUTICALS INC11CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD2KIM DAE YONG1MURPHY TIMOTHY F1REGOR PHARMACEUTICALS INC1
Top patents by PatentIndex Score
19 records- 0190US9278963B2Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·17 cites·24 claims
- 0289US9663825B2Biomarkers to identify patients that will respond to treatment and treating such patientsYANG MIN·Filed 2013·Granted May 30, 2017·10 cites·5 claims
- 0386US9403779B2Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·10 cites·4 claims
- 0480US10648038B2Biomarkers to identify patients that will respond to treatment and treating such patientsACETYLON PHARMACEUTICALS INC·Filed 2017·Granted May 12, 2020·1 cites·7 claims
- 0580US9833466B2Treatment of leukemia with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·5 cites·10 claims
- 0676US10722512B2Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Jul 28, 2020·1 cites·6 claims
- 0774US2023364083A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0864US2020405716A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0964US2023203425A1Method for separating stromal vascular fraction from adipose tissue using non-contact ultrasonic device, and non-contact ultrasonic device used thereinYANG MIN AH·Filed 2022·Application pending·0 cites
- 1062US2025051307A1Salt of 3,4-dihydroisoquinoline compound and use thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2022·Application pending·0 cites
- 1162US2025282797A1Crystalline form of fgfr4 inhibitor and use thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2023·Application pending·0 cites
- 1260US2025136607A1Pad4 inhibitors and use thereofREGOR PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1359US2025092067A1APT1 and APT2 Inhibitors and Uses ThereofUNIV CORNELL·Filed 2022·Application pending·0 cites
- 1456US2015176076A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1548US2014357512A1Histone deacetylase (hdac) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1643US8501197B2Compositions and methods for stimulating immune response against Moraxella catarrhalisMURPHY TIMOTHY F·Filed 2011·Granted Aug 6, 2013·0 cites·14 claims
- 1742US2016279128A1Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1840US2018265829A1Kit for isolating adipose tissue-derived stromal vascular fraction and method for isolating adipose tissue-derived stromal vascular fraction using sameKIM DAE YONG·Filed 2015·Application pending·0 cites
- 1940US2016339022A1Treatment of neuroblastoma with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Min Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →